Effect of Cannabis on Simulated and Actual Driving in Healthy Subjects

NCT ID: NCT01118364

Last Updated: 2014-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-05-31

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Assess the effect of cigarette smoking of tobacco with or without addition of resin cannabis on driving performance in healthy volunteers in simulated driving in Marseille and Toulouse, and in real world driving to Bordeaux.

Multicenter Study of phase 1, randomized, double-blind, cross plan, carried out in healthy male volunteers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* To compare performance data driving with the data self-assessed on the ability to drive, and the level of sleepiness and fatigue
* To measure the effects of distractive task on driving performance, consisting of a conversation with co-driver of the real or simulated vehicle (a series of difficult questions involving reflection)
* To validate the (known) effects of cannabis
* To adapt equipment and standardize methods for the pharmacological studies evaluating other types of substances having an impact on driving (antihistamines, antidepressants, antiparkinsonian ...) and other populations of subjects (men versus women, young versus elderly, healthy versus sick ...)
* To compare data obtained under conditions of simulated driving and actual driving situation, under identical experimental conditions (volunteers, narcotic substance, experimental) and measure the degree of ecological validity of the simulation of driving

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

cigarette with cannabis

a cigarette tobacco trade mark "Drum" with the addition of 250 mg of cannabis resin with 8% of D9THC (20 mg per cigarette)

Group Type EXPERIMENTAL

Cannabis

Intervention Type OTHER

a cigarette tobacco trade mark "Drum" with the addition of 250 mg of cannabis resin with 8% of D9THC (20 mg per cigarette)45 minutes before simulating or real driving

cigarette without cannabis

a cigarette tobacco trade mark "Drum"

Group Type OTHER

tobacco

Intervention Type OTHER

a cigarette tobacco trade mark "Drum" 45 minutes before simulating or real driving

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cannabis

a cigarette tobacco trade mark "Drum" with the addition of 250 mg of cannabis resin with 8% of D9THC (20 mg per cigarette)45 minutes before simulating or real driving

Intervention Type OTHER

tobacco

a cigarette tobacco trade mark "Drum" 45 minutes before simulating or real driving

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Weight +/- 10% of ideal weight
* Tobacco smoker moderate
* Having already smoked of the cannabis (less 1 time per month)
* Not consuming in a way exaggerated by some coffee, tea or cola
* Not having acute or chronic pathologies
* Normal electrocardiogram
* Not taking a drug interfering with the study
* Not presenting disorder of sleeping
* Having a driving license for at least 3 years and driving more 3000 km per year
* Normal acuteness or corrected visual acuteness and normal vision of colors
* Reachable and available during the study
* No nausea or vomit during using of a driving simulator
* Having a national insurance scheme
* Volunteer

Exclusion Criteria

* Women
* Weight deviating of 10% of ideal weight
* Consuming moreover 5 cup of caffeine drinks
* Drinking alcohol regularly
* Acute or chronic pathologies interfering with the study
* Abnormal electrocardiogram
* Asthmatic
* Dependence present or spent in a psychotropic substance
* Presenting an anxious or depressive syndrome
* Circadian typology (Horne et Ostberg)
* Positive control in the cannabis in urines the day of the balance assessment of inclusion
* Positive control in alcohol the day of the balance assessment of inclusion
* Participating in another clinical study
* Having collected an upper total amount of compensations allowances
* Deprived of freedom further to a court or administrative order
* Risk of not observance
* Duration average of sleep of 3 nights previous every session lower than 80 % of the average duration of sleep which the volunteer thinks of needing to be in shape
Minimum Eligible Age

25 Years

Maximum Eligible Age

35 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique Hopitaux De Marseille

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

direction de la recherche

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Assistance Hôpitaux de Marseille

Marseille, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2009/24

Identifier Type: REGISTRY

Identifier Source: secondary_id

2009-A00940-57

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Brief Intervention for Cannabis Use
NCT06395389 RECRUITING NA